Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Tildrakizumab-asmn 100 Mg/ml Subcut Sosy (CDM CP17736969425511464) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 14, 2026 , from http://ppman.hank.ai/transparency/procedure/CP17736969425511464/by-state?code_type=CDM
“Tildrakizumab-asmn 100 Mg/ml Subcut Sosy (CDM CP17736969425511464) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/CP17736969425511464/by-state?code_type=CDM. Accessed
November 14, 2026 .
“Tildrakizumab-asmn 100 Mg/ml Subcut Sosy (CDM CP17736969425511464) by State,” HANK Price Transparency ,
accessed November 14, 2026 ,
http://ppman.hank.ai/transparency/procedure/CP17736969425511464/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
CP17736969425511464 — Tildrakizumab-asmn 100 Mg/ml Subcut Sosy
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$12,138
National median
$10,712 – $14,739
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for CP17736969425511464 (CDM), with interquartile range
State Median p25 p75
ND $12,138 $10,712 $14,739